AF
BBNX

Allworth Financial’s Beta Bionics BBNX Stock Holding History

Allworth Financial’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38K Buy
238
+219
+1,153% +$3.24K ﹤0.01% 4293
2025
Q4 		$579 Buy
19
+17
+850% +$454 ﹤0.01% 4496
2025
Q3 		$40 Buy
+2
New +$35 ﹤0.01% 4771

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Allworth Financial's BBNX Position: Q1 2026 in Review

Allworth Financial increased its Beta Bionics (BBNX) stake by 1,153% in Q1 2026, buying an estimated $3.24K and bringing the position to 238 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4293.

Allworth Financial first reported a position in BBNX in Q3 2025 and has held it in 3 quarters since. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Allworth Financial held 238 shares of Beta Bionics worth $2.38K as of Q1 2026.
  • Allworth Financial bought 219 Beta Bionics shares in Q1 2026, an estimated $3.24K.
  • Beta Bionics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4293 holding.
  • Allworth Financial first reported a position in Beta Bionics in Q3 2025 and has held it in 3 quarters since.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.